Human aldo–keto reductases 1B1 and 1B10: A comparative study on their enzyme activity toward electrophilic carbonyl compounds
- 30 May 2011
- journal article
- research article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 191 (1-3), 192-198
- https://doi.org/10.1016/j.cbi.2011.02.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Aldo–keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levelsBiochemical and Biophysical Research Communications, 2009
- Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating CarbonylsJournal of Biological Chemistry, 2009
- Aldo-keto reductases from the AKR1B subfamily: Retinoid specificity and control of cellular retinoic acid levelsChemico-Biological Interactions, 2009
- Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydesChemico-Biological Interactions, 2009
- Cancer biomarker AKR1B10 and carbonyl metabolismChemico-Biological Interactions, 2009
- Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formationCarcinogenesis: Integrative Cancer Research, 2008
- Oxidation of PAH trans-Dihydrodiols by Human Aldo-Keto Reductase AKR1B10Chemical Research in Toxicology, 2008
- The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and DetoxificationDrug Metabolism Reviews, 2008
- Structural basis for the high all-trans -retinaldehyde reductase activity of the tumor marker AKR1B10Proceedings of the National Academy of Sciences of the United States of America, 2007
- PURIFICATION AND CHARACTERIZATION OF AKR1B10 FROM HUMAN LIVER: ROLE IN CARBONYL REDUCTION OF XENOBIOTICSDrug Metabolism and Disposition, 2005